(Q38648357)

5 September 2017

1 reference

title

The development of iron chelating drugs (English)

1 reference

5 September 2017

1

1 reference

5 September 2017

Huehns ER

2

1 reference

5 September 2017

Hider RC

series ordinal

3

1 reference

5 September 2017

language of work or name

1 reference

1 April 1989

1 reference

Best Practice and Research: Clinical Haematology

5 September 2017

published in

1 reference

5 September 2017

volume

2

1 reference

5 September 2017

issue

2

1 reference

5 September 2017

page(s)

257-292

1 reference

Non-transferrin plasma iron in beta-thalassaemia/Hb E and haemoglobin H diseases

5 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2889%2980018-6

7 January 2021

Rhodotorulic acid, a diketopiperazine dihydroxamic acid with growth-factor activity. I. Isolation and characterization

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2889%2980018-6

7 January 2021

Syntheses of iron bis(pyridoxal isonicotinoylhydrazone)s and the in vivo iron-removal properties of some pyridoxal derivatives

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2889%2980018-6

7 January 2021

The effect of carbon dioxide, lidoflazine and deferoxamine upon long term survival following cardiorespiratory arrest in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2889%2980018-6

7 January 2021

Iron release from isolated hepatocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2889%2980018-6

7 January 2021

Iron chelation by pyridoxal isonicotinoyl hydrazone and analogues in hepatocytes in culture.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2889%2980018-6

7 January 2021

Measurement of iron stores using deferoxamine

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2889%2980018-6

7 January 2021

Effect of Desferrioxamine and D.T.P.A. in Iron Overload

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2889%2980018-6

7 January 2021

Long-term Chelation Therapy in Thalassaemia Major: Effect on Liver Iron Concentration, Liver Histology, and Clinical Progress

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2889%2980018-6

7 January 2021

A non-transferrin-bound serum iron in idiopathic hemochromatosis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2889%2980018-6

7 January 2021

Catechol O-methyltransferase. 4. In vitro inhibition by 3-hydroxy-4-pyrones, 3-hydroxy-2-pyridones, and 3-hydroxy-4-pyridones

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2889%2980018-6

7 January 2021

The nature of iron released by resident and stimulated mouse peritoneal macrophages

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2889%2980018-6

7 January 2021

The effect of iron on the distribution of superoxide and hydroxyl radicals as seen by spin trapping and on the superoxide dismutase assay

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2889%2980018-6

7 January 2021

Leukotriene biosynthesis inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2889%2980018-6

7 January 2021

Clinical management of thalassemia. The status of new iron chelators

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2889%2980018-6

7 January 2021

Biliary iron excretion in rats following pyridoxal isonicotinoyl hydrazone

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2889%2980018-6

7 January 2021

Synthetic chelating agents in iron metabolism

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2889%2980018-6

7 January 2021

Transferrin binding and iron uptake in mouse hepatocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2889%2980018-6

7 January 2021

Iron mobilization from ferritin by chelating agents

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2889%2980018-6

7 January 2021

Reductive mobilisation of ferritin iron.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2889%2980018-6

7 January 2021

Effect of various iron chelating agents on DNA synthesis in human cells

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2889%2980018-6

7 January 2021

Clinical trial of desferrioxamine entrapped in red cell ghosts

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2889%2980018-6

7 January 2021

Some aspects of iron uptake by rat hepatocytes in suspension

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2889%2980018-6

7 January 2021

Feasibility of enterochelin as an iron-chelating drug: Studies with human serum and a mouse model system

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2889%2980018-6

7 January 2021

Low-molecular-weight iron complexes and oxygen radical reactions in idiopathic haemochromatosis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2889%2980018-6

7 January 2021

In vivo evaluation of hydroxypyridone iron chelators in a mouse model

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2889%2980018-6

7 January 2021

THE EFFECT OF DESFERRIOXAMINE ON IRON METABOLISM IN MAN

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2889%2980018-6

7 January 2021

Oxygen toxicity, oxygen radicals, transition metals and disease

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2889%2980018-6

7 January 2021

Evaluation of storage iron by chelates

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2889%2980018-6

7 January 2021

Mechanism of Desferrioxamine-Induced Iron Excretion in Thalassaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2889%2980018-6

7 January 2021

Non-specific serum iron in thalassaemia: an abnormal serum iron fraction of potential toxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2889%2980018-6

7 January 2021

Effective Iron Chelation following Oral Administration of an Isoniazid-Pyridoxal Hydrazone

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2889%2980018-6

7 January 2021

Selection of hydroxypyridin-4-ones for the treatment of iron overload using in vitro and in vivo models

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2889%2980018-6

7 January 2021

Receptor-mediated endocytosis of transferrin by developing erythroid cells from the fetal rat liver

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2889%2980018-6

7 January 2021

Desferrioxamine Chelatable Iron in Haemolytic, Megaloblastic and Sideroblastic Anaemias*

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2889%2980018-6

7 January 2021

THE BIOCHEMISTRY OF DESFERRIOXAMINE AND ITS RELATION TO IRON METABOLISM

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2889%2980018-6

7 January 2021

Mobilisation of Iron from Peritoneal Rat Macrophages by Desferrioxamine

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2889%2980018-6

7 January 2021

Paraquat toxicity is enhanced by iron and reduced by desferrioxamine in laboratory mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2889%2980018-6

7 January 2021

The study of iron mobilisation from transferrin using alpha-ketohydroxy heteroaromatic chelators

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2889%2980018-6

7 January 2021

Dose response studies using desferrioxamine and orally active chelators in a mouse model

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2889%2980018-6

7 January 2021

Orally active alpha-ketohydroxy pyridine iron chelators intended for clinical use: in vivo studies in rabbits

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2889%2980018-6

7 January 2021

1,2-Dimethyl-3-hydroxypyrid-4-one, an orally active chelator for treatment of iron overload

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2889%2980018-6

7 January 2021

Iron chelation studies using desferrioxamine and the potential oral chelator, 1,2-dimethyl-3-hydroxypyrid-4-one, in normal and iron loaded rats

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2889%2980018-6

7 January 2021

Effective chelation of iron in beta thalassaemia with the oral chelator 1,2-dimethyl-3-hydroxypyrid-4-one.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2889%2980018-6

7 January 2021

Cellular pharmacology of deferrioxamine B and derivatives in cultured rat hepatocytes in relation to iron mobilization

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2889%2980018-6

7 January 2021

An animal model of iron overload and its application to study hepatic ferritin iron mobilization by chelators

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2889%2980018-6

7 January 2021

Assay of tissue ferritin

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2889%2980018-6

7 January 2021

Synergistic chelation therapy or mixed ligand complexes for plutonium and cadmium poisoning?

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2889%2980018-6

7 January 2021

Total management of thalassaemia major

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2889%2980018-6

7 January 2021

Survival and desferrioxamine in thalassaemia major.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2889%2980018-6

7 January 2021

Studies on the mechanism of iron release from transferrin

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2889%2980018-6

7 January 2021

Microbial Envelope Proteins Related to Iron

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2889%2980018-6

7 January 2021

Ascorbic acid enhancement of desferrioxamine-induced urinary iron excretion in thalassemia major

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2889%2980018-6

7 January 2021

Iron mobilization from cultured hepatocytes: effect of desferrioxamine B

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2889%2980018-6

7 January 2021

Chelation studies with 2,3-dihydroxybenzoic acid in patients with beta-thalassaemia major

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2889%2980018-6

7 January 2021

Hepatocyte iron kinetics in the rat explored with an iron chelator

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2889%2980018-6

7 January 2021

Iron chelation using subcutaneous infusions of diethylene triamine penta-acetic acid (DTPA).

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2889%2980018-6

7 January 2021

Esters and lactones of phenolic amino carboxylic acids: prodrugs for iron chelation

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2889%2980018-6

7 January 2021

The quantitative determination of iron kinetics and hemoglobin synthesis in human subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2889%2980018-6

7 January 2021

A study of intracellular iron metabolism using pyridoxal isonicotinoyl hydrazone and other synthetic chelating agents

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2889%2980018-6

7 January 2021

Mobilization of iron from reticulocytes. Identification of pyridoxal isonicotinoyl hydrazone as a new iron chelating agent

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2889%2980018-6

7 January 2021

DESFERRIOXAMINE AND SYSTEMIC YERSINIOSIS

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2889%2980018-6

7 January 2021

High weekly intravenous doses of desferrioxamine in porphyria cutanea tarda

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2889%2980018-6

7 January 2021

Preliminary toxicity findings in dogs and rodents given the iron chelator ethylenediamine-N,N'-bis(2-hydroxyphenylacetic acid) (EDHPA)

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2889%2980018-6

7 January 2021

A five-coordinate copper complex with superoxide dismutase mimetic activity from Streptomyces antibioticus

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2889%2980018-6

7 January 2021

Iron excretion in thalassaemia major after administration of chelating agents

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2889%2980018-6

7 January 2021

Colorimetric detection of the hydroxyl radical: Comparison of the hydroxyl-radical-generating ability of various iron complexes

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2889%2980018-6

7 January 2021

Siderophore-mediated iron acquisition from transferrin by Pseudomonas aeruginosa

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2889%2980018-6

7 January 2021

Orally active hydroxamic acid inhibitors of leukotriene biosynthesis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2889%2980018-6

7 January 2021

Microcomputer application of non-linear regression analysis to metal-ligand equilibria

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2889%2980018-6

7 January 2021

Uptake of iron from transferrin by isolated hepatocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2889%2980018-6

7 January 2021

Catalytic oxidation of 2-aminophenols and ortho hydroxylation of aromatic amines by tyrosinase

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2889%2980018-6

7 January 2021

1,3,5-Tris(N,N',N"-2,3-dihydroxybenzoyl)aminomethylbenzene, a synthetic iron chelator related to enterobactin

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2889%2980018-6

7 January 2021

Non-transferrin-bound iron in long-term transfusion in children with congenital anemias

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2889%2980018-6

7 January 2021

Iron withholding: a defense against infection and neoplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2889%2980018-6

7 January 2021

The use of chang cells cultured in vitro to evaluate potential iron chelating drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2889%2980018-6

7 January 2021

Pyridoxal complexes as potential chelating agents for oral therapy in transfusional iron overload.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2889%2980018-6

7 January 2021

https://api.crossref.org/works/10.1016%2FS0950-3536%2889%2980018-6

1 reference

7 January 2021

The effect of desferrioxamine on antigen-induced inflammation in the rat air pouch

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2889%2980018-6

7 January 2021

Liposome entrapped desferrioxamine and iron transporting ionophores: a new approach to iron chelation therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2889%2980018-6

7 January 2021

10.1016/S0950-3536(89)80018-6

Identifiers

DOI

1 reference

5 September 2017

1 reference